R. Livingston
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 10%
- Pharmacology top 10%
- Radiation top 5%
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Charles ScottA. Rashid DarRoger W. ByhardtWalter J. CurranJ.D. CoxD. JohnsonB. EmamiRitsuko Komaki
- Topics
- Drug-Induced Adverse Reactions (3 papers)Antibiotics Pharmacokinetics and Efficacy (3 papers)Lung Cancer Treatments and Mutations (3 papers)
- Journals
- Journal of Clinical OncologyJNCI Journal of the National Cancer InstituteAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
R. Livingston
12 papers receiving 710 citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Pulmonary and Respiratory Medicine 523
- Oncology 342
- Pharmacology 126
- Radiation 121
- Radiology, Nuclear Medicine and Imaging 84
Countries citing papers authored by R. Livingston
This map shows the geographic impact of R. Livingston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Livingston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Livingston more than expected).
Fields of papers citing papers by R. Livingston
This network shows the impact of papers produced by R. Livingston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Livingston. The network helps show where R. Livingston may publish in the future.
Co-authorship network of co-authors of R. Livingston
This figure shows the co-authorship network connecting the top 25 collaborators of R. Livingston. A scholar is included among the top collaborators of R. Livingston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Livingston. R. Livingston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 6 | |
| 3 | 4 | |
| 4 | 15 | |
| 5 | Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancerbreakdown → | 541 |
| 6 | Engraftment in 86 patients with lymphoid malignancy after autologous marrow transplantation | 35 |
| 7 | 12 | |
| 8 | 40 | |
| 9 | 92 | |
| 10 | 2 | |
| 11 | 39 | |
| 12 | 1 |
About R. Livingston
R. Livingston is a scholar working on Pharmacology, Molecular Medicine and Hematology, having authored 12 papers that have together received 789 indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (523 citations), Radiation (121 citations) and Oncology (342 citations). R. Livingston has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Charles Scott, A. Rashid Dar, Roger W. Byhardt, Walter J. Curran, J.D. Cox, D. Johnson, B. Emami, Ritsuko Komaki, Robert A. Wise and A.P. Gillett. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.